What is MedTech?
MedTech operates as a high-authority industry association, serving as the connective tissue for New York State's robust Bio/Med sector. With a membership base exceeding 100 entities—ranging from research-intensive universities to commercial pharmaceutical and medical technology firms—the organization facilitates critical collaboration, educational programming, and policy advocacy. For over a decade, MedTech has functioned as a catalyst for industrial success, providing the infrastructure necessary for its members to navigate complex regulatory environments and scale their innovative research into market-ready solutions.
How much funding has MedTech raised?
MedTech has raised a total of $49K across 1 funding round:
Debt
$49K
Debt (2021): $49K with participation from PPP
Key Investors in MedTech
PPP
Public-Private Partnership
What's next for MedTech?
With the infusion of $49K, MedTech is poised to enter a new phase of operational scaling. The organization is expected to prioritize the expansion of its advocacy efforts and the enhancement of its collaborative research platforms. By strengthening the ties between academic research institutions and commercial suppliers, MedTech aims to solidify New York's position as a global leader in medical innovation. Future strategic developments will likely focus on digital transformation within the biotech supply chain and the cultivation of a specialized workforce to support the next generation of medical technology breakthroughs.
See full MedTech company page
